The store will not work correctly when cookies are disabled.
(4R)-4-[[(5-chloro-8-quinolyl)methylamino]methyl]-1-cyclopropyl-pyrrolidin-2-one
ID: ALA5094012
PubChem CID: 166635852
Max Phase: Preclinical
Molecular Formula: C18H20ClN3O
Molecular Weight: 329.83
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C[C@H](CNCc2ccc(Cl)c3cccnc23)CN1C1CC1
Standard InChI: InChI=1S/C18H20ClN3O/c19-16-6-3-13(18-15(16)2-1-7-21-18)10-20-9-12-8-17(23)22(11-12)14-4-5-14/h1-3,6-7,12,14,20H,4-5,8-11H2/t12-/m1/s1
Standard InChI Key: RMLDETFEMQHVSC-GFCCVEGCSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-2.8489 0.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1344 0.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4224 0.3853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4224 -0.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1325 -0.8515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8489 -0.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1283 -1.6735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8399 -2.0902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5536 -1.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5635 -0.8618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5631 0.7973 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.7083 -0.8521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0058 -0.4397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7201 -0.8521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4342 -0.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5203 0.3799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3266 0.5513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7388 -0.1624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1872 -0.7751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5635 -0.1624 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7390 1.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4545 1.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7399 2.0902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
5 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
6 10 1 0
1 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
15 14 1 6
16 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 1 0
18 20 2 0
21 17 1 0
21 22 1 0
21 23 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.83 | Molecular Weight (Monoisotopic): 329.1295 | AlogP: 2.99 | #Rotatable Bonds: 5 |
Polar Surface Area: 45.23 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.57 | CX LogP: 1.89 | CX LogD: -0.25 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.92 | Np Likeness Score: -1.26 |
References
1. Levit Kaplan A, Strachan RT, Braz JM, Craik V, Slocum S, Mangano T, Amabo V, O'Donnell H, Lak P, Basbaum AI, Roth BL, Shoichet BK.. (2022) Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor., 65 (5.0): [PMID:35195401] [10.1021/acs.jmedchem.1c02031] |